Total Payments
$5,727
2024 Payments
$26.80
Companies
4
Transactions
19
Medicare Patients
705
Medicare Billing
$124,885
Payment Breakdown by Category
Other$4,329 (75.6%)
Consulting$1,000 (17.5%)
Research$219.00 (3.8%)
Food & Beverage$179.60 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,329 | 13 | 75.6% |
| Consulting Fee | $1,000 | 1 | 17.5% |
| Unspecified | $219.00 | 1 | 3.8% |
| Food and Beverage | $179.60 | 4 | 3.1% |
Payments by Type
General
$5,508
18 transactions
Research
$219.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim International GmbH | $4,329 | 13 | $0 (2022) |
| AVEO Pharmaceuticals, Inc. | $1,127 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $245.00 | 3 | $0 (2023) |
| Daiichi Sankyo Inc. | $26.80 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.80 | 1 | Daiichi Sankyo Inc. ($26.80) |
| 2023 | $26.00 | 2 | Novartis Pharmaceuticals Corporation ($26.00) |
| 2022 | $3,386 | 9 | Boehringer Ingelheim International GmbH ($2,260) |
| 2021 | $2,069 | 6 | Boehringer Ingelheim International GmbH ($2,069) |
| 2020 | $219.00 | 1 | Novartis Pharmaceuticals Corporation ($219.00) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2023 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Oncology | ||||||
| 03/13/2023 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Oncology | ||||||
| 10/28/2022 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $513.42 | General |
| 10/28/2022 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $232.67 | General |
| 10/28/2022 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $95.91 | General |
| 10/04/2022 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 10/04/2022 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $126.80 | General |
| Category: Oncology | ||||||
| 06/30/2022 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $513.42 | General |
| 06/30/2022 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $462.08 | General |
| 06/30/2022 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $232.67 | General |
| 06/30/2022 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $209.40 | General |
| 11/10/2021 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $556.10 | General |
| 09/16/2021 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $484.73 | General |
| 09/13/2021 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $95.91 | General |
| 07/15/2021 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $209.40 | General |
| 06/04/2021 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $505.55 | General |
| 06/04/2021 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $217.24 | General |
| 01/30/2020 | Novartis Pharmaceuticals Corporation | BLZ495X (Drug) | — | In-kind items and services | $219.00 | Research |
| Study: RESEARCH RELATED PUBLICATIONS SUPPORT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | Novartis Pharmaceuticals Corporation | $219.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 153 | 170 | $86,042 | $19,748 |
| 2022 | 3 | 178 | 199 | $100,463 | $27,270 |
| 2021 | 2 | 173 | 208 | $89,959 | $25,543 |
| 2020 | 6 | 201 | 239 | $282,410 | $52,325 |
Total Patients
705
Total Services
816
Medicare Billing
$124,885
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 87 | 104 | $47,828 | $10,674 | 22.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 66 | 66 | $38,214 | $9,074 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 92 | 113 | $45,542 | $12,501 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 74 | 74 | $42,477 | $9,939 | 23.4% |
| 49999 | Other procedure on abdomen | Facility | 2022 | 12 | 12 | $12,444 | $4,830 | 38.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 107 | 142 | $53,920 | $15,808 | 29.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 66 | 66 | $36,039 | $9,734 | 27.0% |
| 47120 | Partial removal of liver lobe | Facility | 2020 | 13 | 19 | $173,812 | $29,275 | 16.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 84 | 116 | $41,619 | $9,892 | 23.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 43 | 43 | $37,353 | $5,880 | 15.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 32 | 32 | $14,476 | $3,278 | 22.6% |
| 49905 | Placement of flap to repair abdominal wall | Facility | 2020 | 11 | 11 | $10,362 | $3,096 | 29.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 18 | 18 | $4,788 | $904.38 | 18.9% |
About Dr. Todd Bauer, M.D
Dr. Todd Bauer, M.D is a Surgical Oncology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568551034.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Bauer, M.D has received a total of $5,727 in payments from pharmaceutical and medical device companies, with $26.80 received in 2024. These payments were reported across 19 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,329).
As a Medicare-enrolled provider, Bauer has provided services to 705 Medicare beneficiaries, totaling 816 services with total Medicare billing of $124,885. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical Oncology
- Location Charlottesville, VA
- Active Since 10/12/2006
- Last Updated 08/08/2023
- Taxonomy Code 2086X0206X
- Entity Type Individual
- NPI Number 1568551034
Products in Payments
- FOTIVDA (Drug) $1,127
- BLZ495X (Drug) $219.00
- Enhertu (Drug) $26.80
- LUTATHERA (Drug) $26.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Oncology Doctors in Charlottesville
Dr. Allan Tsung, Md, MD
Surgical Oncology — Payments: $15,360
Surgical Oncology $15,360
Shayna Showalter, M.d, M.D
Surgical Oncology — Payments: $4,629
Surgical Oncology $4,629
Reid Adams
Surgical Oncology — Payments: $1,029
Surgical Oncology $1,029
Craig Slingluff, M.d, M.D
Surgical Oncology — Payments: $82.08
Surgical Oncology $82.08
David Brenin, Md, MD
Surgical Oncology
Surgical Oncology
Anneke Schroen, Md, MD
Surgical Oncology
Surgical Oncology